JMP Securities Downgrades Cerus (CERS) to Market Underperform
CERS Hot Sheet
Rating Summary:4 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 16 | Down: 7 | New: 23
JMP Securities downgrades Cerus (Nasdaq: CERS) from Market Perform to Market Underperform.
Cerus Corporation, a biomedical products company, engages in the development and commercialization of the INTERCEPT Blood System.
Cerus Corporation, a biomedical products company, engages in the development and commercialization of the INTERCEPT Blood System.
You May Also Be Interested In
- UPDATE: UBS Downgrades Wisconsin Energy (WEC) to Neutral; Taking Some Off The Table
- Jefferies Downgrades Heinz (HNZ) to Hold
- Barclays Cuts Estimates and Price Target on ADP (ADP); Mixed Data From Investor Day
Create E-mail Alert Related Categories
DowngradesRelated Entities
JMP SecuritiesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
